Literature DB >> 16086581

Functional interactions of Raf and MEK with Jun-N-terminal kinase (JNK) result in a positive feedback loop on the oncogenic Ras signaling pathway.

Victor Adler1, Yongxia Qu, Steven J Smith, Lara Izotova, Sidney Pestka, Hsiang-Fu Kung, Marie Lin, Fred K Friedman, Lyndon Chie, Denise Chung, Mohamed Boutjdir, Matthew R Pincus.   

Abstract

In previous studies we have found that oncogenic (Val 12)-ras-p21 induces Xenopus laevis oocyte maturation that is selectively blocked by two ras-p21 peptides, 35-47, also called PNC-7, that blocks its interaction with raf, and 96-110, also called PNC-2, that blocks its interaction with jun-N-terminal kinase (JNK). Each peptide blocks activation of both JNK and MAP kinase (MAPK or ERK) suggesting interaction between the raf-MEK-ERK and JNK-jun pathways. We further found that dominant negative raf blocks JNK induction of oocyte maturation, again suggesting cross-talk between pathways. In this study, we have undertaken to determine where these points of cross-talk occur. First, we have immunoprecipitated injected Val 12-Ha-ras-p21 from oocytes and found that a complex forms between ras-p21 raf, MEK, MAPK, and JNK. Co-injection of either peptide, but not a control peptide, causes diminished binding of ras-p21, raf, and JNK. Thus, one site of interaction is cooperative binding of Val 12-ras-p21 to raf and JNK. Second, we have injected JNK, c-raf, and MEK into oocytes alone and in the presence of raf and MEK inhibitors and found that JNK activation is independent of the raf-MEK-MAPK pathway but that activated JNK activates raf, allowing for activation of ERK. Furthermore, we have found that constitutively activated MEK activates JNK. We have corroborated these findings in studies with isolated protein components from a human astrocyte (U-251) cell line; that is, JNK phosphorylates raf but not the reverse; MEK phosphorylates JNK but not the reverse. We further have found that JNK does not phosphorylate MAPK and that MAPK does not phosphorylate JNK. The stress-inducing agent, anisomycin, causes activation of JNK, raf, MEK, and ERK in this cell line; activation of JNK is not inhibitable by the MEK inhibitor, U0126, while activation of raf, MEK, and ERK are blocked by this agent. These results suggest that activated JNK can, in turn, activate not only jun but also raf that, in turn, activates MEK that can then cross-activate JNK in a positive feedback loop.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16086581     DOI: 10.1021/bi050619j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  BPGAP1 spatially integrates JNK/ERK signaling crosstalk in oncogenesis.

Authors:  T Jiang; C Q Pan; B C Low
Journal:  Oncogene       Date:  2017-01-16       Impact factor: 9.867

2.  Nonmineralized and Mineralized Collagen Scaffolds Induce Differential Osteogenic Signaling Pathways in Human Mesenchymal Stem Cells.

Authors:  Qi Zhou; Xiaoyan Ren; David Bischoff; Daniel W Weisgerber; Dean T Yamaguchi; Timothy A Miller; Brendan A C Harley; Justine C Lee
Journal:  Adv Healthc Mater       Date:  2017-09-25       Impact factor: 9.933

3.  Regulation of endothelial MAPK/ERK signalling and capillary morphogenesis by low-amplitude electric field.

Authors:  Abdul Q Sheikh; Toloo Taghian; Bryan Hemingway; Hongkwan Cho; Andrei B Kogan; Daria A Narmoneva
Journal:  J R Soc Interface       Date:  2012-09-19       Impact factor: 4.118

4.  FR180204, a novel and selective inhibitor of extracellular signal-regulated kinase, ameliorates collagen-induced arthritis in mice.

Authors:  Makoto Ohori; Mikio Takeuchi; Riyo Maruki; Hidenori Nakajima; Hiroshi Miyake
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-11-23       Impact factor: 3.000

5.  RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets.

Authors:  O A Kent; K Fox-Talbot; M K Halushka
Journal:  Oncogene       Date:  2012-07-02       Impact factor: 9.867

6.  Endothelial nitric-oxide synthase activation generates an inducible nitric-oxide synthase-like output of nitric oxide in inflamed endothelium.

Authors:  Jessica L Lowry; Viktor Brovkovych; Yongkang Zhang; Randal A Skidgel
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

7.  Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancer.

Authors:  Wilbur B Bowne; Josef Michl; Martin H Bluth; Michael E Zenilman; Matthew R Pincus
Journal:  Cancer Ther       Date:  2007

8.  Fibroblast growth factor 2 upregulates ecto-5'-nucleotidase and adenosine deaminase via MAPK pathways in cultured rat spinal cord astrocytes.

Authors:  Ryota Eguchi; Taisuke Kitano; Ken-Ichi Otsuguro
Journal:  Purinergic Signal       Date:  2020-10-06       Impact factor: 3.765

9.  Neurofilament tail phosphorylation: identity of the RT-97 phosphoepitope and regulation in neurons by cross-talk among proline-directed kinases.

Authors:  Ju-Hyun Lee; Tej K Pareek; Howard Jaffee; Barry Boland; K Yaragudri Vinod; Niranjana Amin; Ashok B Kulkarni; Harish C Pant; Ralph A Nixon
Journal:  J Neurochem       Date:  2008-07-04       Impact factor: 5.372

10.  Learning robust cell signalling models from high throughput proteomic data.

Authors:  Mitchell Koch; Bradley M Broom; Devika Subramanian
Journal:  Int J Bioinform Res Appl       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.